Paul Kenna
Founder at Spark Therapeutics Ireland Ltd.
Paul Kenna active positions
Companies | Position | Start | End |
---|---|---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Chief Tech/Sci/R&D Officer | 31/08/2004 | - |
Founder | - | - | |
Trinity College Dublin | Corporate Officer/Principal | - | - |
The Royal College of Physicians | Corporate Officer/Principal | - | - |
Irish College of Ophthalmologists | Corporate Officer/Principal | - | - |
Career history of Paul Kenna
Training of Paul Kenna
Trinity College Dublin | Doctorate Degree |
Statistics
International
Ireland | 4 |
United Kingdom | 2 |
Operational
Corporate Officer/Principal | 3 |
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 1 |
---|---|
Spark Therapeutics Ireland Ltd.
Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Health Technology |
- Stock Market
- Insiders
- Paul Kenna
- Experience